vimarsana.com
Home
Live Updates
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With Unique, But Pretty Simple Drug - Travere Therapeutics (NASDAQ:TVTX), Calliditas Therapeutics (NASDAQ:CALT), SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI) : comparemela.com
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug - Travere Therapeutics (NASDAQ:TVTX), Calliditas Therapeutics (NASDAQ:CALT), SPDR Series Trust SPDR S&P Biotech ETF (ARCA:XBI)
Calliditas, a rare disease company focused on kidney ailments, is optimistic of its lead drug taking off in a big way.
Related Keywords
Sweden ,
China ,
United States ,
American ,
Swedish ,
Renee Aguiar Lucander ,
Travere Filspari ,
Travere Therapeutics Inc ,
,
Calliditas Therapeutics ,
Best Biotech ,
Orphan Drug ,
Travere Therapeutics ,
Prescription Drug User Fee Act ,
Nasdaq Listed American Depository ,
Benzinga Pro ,
comparemela.com © 2020. All Rights Reserved.